The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
Nature Medicine2015Vol. 21(10), pp. 1199–1208
Citations Over TimeTop 1% of 2015 papers
Ana Ortega-Molina, Isaac W. Boss, Andrés Canela, Heng Pan, Yanwen Jiang, Chunying Zhao, Man Jiang, Deqing Hu, Xabier Agirre, Itamar Niesvizky, Ji‐Eun Lee, Hua-Tang Chen, Daisuke Ennishi, David W. Scott, Anja Mottok, Christoffer Hother, Shichong Liu, Xing-Jun Cao, Wayne Tam, Rita Shaknovich, Benjamin A. García, Randy D. Gascoyne, Kai Ge, Ali Shilatifard, Olivier Elemento, André Nussenzweig, Ari Melnick, Hans‐Guido Wendel
Related Papers
- → WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development(2005)814 cited
- → Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3(2005)545 cited
- → Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function(2018)193 cited
- → Development and Implementation of a High-Throughput AlphaLISA Assay for Identifying Inhibitors of EZH2 Methyltransferase(2013)21 cited
- → The Ezh2 methyltransferase complex: actin up in the cytosol(2005)25 cited